glp 1 novo nordisk plans to slash GLP-1 prices GLP-1s for Alzheimer's: Novo Nordisk

Animal model studies consistently demonstrated that semaglutide can significantly alter gut microbiota, suggesting that part of semaglutides metabolic benefit may derive from its capacity to modulate inflammation via gut-immune-microbiota interactions and to correct dysbiosis induced by high-fat diets [82, 84]

The Center for Nutritional Psychology

Common adverse effects associated with probiotic use are typically mild and gastrointestinal in nature: Bloating and gas, especially during the first few days of use Abdominal discomfort or cramping Changes in bowel habits (diarrhea or constipation) Nausea (less common) These symptoms usually resolve within one to two weeks as the gut microbiome adjusts

Chen J, Dong X, Lin Y, Lv C (2025) The critical role of GLP-1 signaling pathways in the pathology of Parkinsons disease and diabetes